Accsl-flox Mouse

Accsl, one of the five hub genes closely related to the occurrence and development of diffuse large B-cell lymphoma (DLBCL), was identified through key driver analysis in a study on gene-expression differences between limited-and advanced-stage DLBCL patients [1]. The gene co-expression modules analysis indicated that DLBCL progression was related to pathways like the NOD-like receptor signaling pathway, neutrophil activation, and functions such as secretory granule membrane and carboxylic acid binding [1].

In this study, a pipeline was used to analyze RNA sequencing data of DLBCL patients. By performing differential gene expression analysis, weighted gene correlation network analysis, and key driver analysis, Accsl was found among the key genes related to DLBCL stage progression [1].

In conclusion, Accsl appears to be an important gene in the context of DLBCL, with its identification contributing to understanding the molecular mechanisms underlying the progression of this lymphoma. The study provides a basis for further exploration of Accsl's role in DLBCL, potentially leading to new treatment strategies.